The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
Open accessAbstract
The mucosal immune system is the largest component of the entire immune system, having evolved to provide protection at the main sites of infectious threat: the mucosae. As SARS-CoV-2 initially infects the upper respiratory tract, its first interactions with the immune system must occur predominantly at the respiratory mucosal surfaces, during both inductive and effector phases of the response. However, almost all studies of the immune response in COVID-19 have focused exclusively on serum antibodies and systemic cell-mediated immunity including innate responses. This article proposes that there is a significant role for mucosal immunity and for secretory as well as circulating IgA antibodies in COVID-19, and that it is important to elucidate this in order to comprehend especially the asymptomatic and mild states of the infection, which appear to account for the majority of cases. Moreover, it is possible that mucosal immunity can be exploited for beneficial diagnostic, therapeutic, or prophylactic purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Sterlin, D., Mathian, A., Miyara, M., Mohr, A., Anna, F., Claër, L., Quentric, P., Fadlallah, J., Devilliers, H., Ghillani, P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd2223 · Cited by 1,037
Viral and host factors related to the clinical outcome of COVID-19
Zhang, X., Tan, Y., Ling, Y., Lu, G., Liu, F., Yi, Z., Jia, X., Wu, M., Shi, B., Xu, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2355-0 · Cited by 885
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
Isho, B., Abe, K. T., Zuo, M., Jamal, A. J., Rathod, B., Wang, J. H., Li, Z., Chao, G., Rojas, O. L., Bang, Y. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abe5511 · Cited by 822
Broad neutralization of SARS-related viruses by human monoclonal antibodies
Wec, A. Z., Wrapp, D., Herbert, A. S., Maurer, D. P., Haslwanter, D., Sakharkar, M., Jangra, R. K., Dieterle, M. E., Lilov, A., Huang, D., et al. (2020) · Science · doi:10.1126/science.abc7424 · Cited by 539
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Cervia, C., Nilsson, J., Zurbuchen, Y., Valaperti, A., Schreiner, J., Wolfensberger, A., Raeber, M. E., Adamo, S., Weigang, S., Emmenegger, M., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.040 · Cited by 408
Tomaras, G. D., Ferrari, G., Shen, X., Alam, S. M., Liao, H.-X., Pollara, J., Bonsignori, M., Moody, M. A., Fong, Y., Chen, X., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301456110 · Cited by 394
The mucosal immune system: master regulator of bidirectional gut-brain communications
Powell, N., Walker, M. M., & Talley, N. J. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.191 · Cited by 379
Intravascular and Mucosal Immunoglobulin A: Two Separate but Related Systems of Immune Defense?
CONLEY, M. E., & DELACROIX, D. L. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-892 · Cited by 375
Secretory immunity with special reference to the oral cavity
Brandtzaeg, P. (2013) · Journal of Oral Microbiology · doi:10.3402/jom.v5i0.20401 · Cited by 318
Bermejo-Martin, J. F., González-Rivera, M., Almansa, R., Micheloud, D., Tedim, A. P., Domínguez-Gil, M., Resino, S., Martín-Fernández, M., Ryan Murua, P., Pérez-García, F., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03398-0 · Cited by 264
IgA subclasses have different effector functions associated with distinct glycosylation profiles
Steffen, U., Koeleman, C. A., Sokolova, M. V., Bang, H., Kleyer, A., Rech, J., Unterweger, H., Schicht, M., Garreis, F., Hahn, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13992-8 · Cited by 263
Tschernig, T., & Pabst, R. (2000) · Pathobiology · doi:10.1159/000028109 · Cited by 228
Quiding-Järbrink, M., Nordström, I., Granström, G., Kilander, A., Jertborn, M., Butcher, E. C., Lazarovits, A. I., Holmgren, J., & Czerkinsky, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119286 · Cited by 216
Human immune responses to influenza virus vaccines administered by systemic or mucosal routes
Moldoveanu, Z., Clements, M. L., Prince, S. J., Murphy, B. R., & Mestecky, J. (1995) · Vaccine · doi:10.1016/0264-410x(95)00016-t · Cited by 184
Self-citationA cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction
Ejemel, M., Li, Q., Hou, S., Schiller, Z. A., Tree, J. A., Wallace, A., Amcheslavsky, A., Kurt Yilmaz, N., Buttigieg, K. R., Elmore, M. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18058-8 · Cited by 167
Russell, M. W., Reinholdt, J., & Kilian, M. (1989) · European Journal of Immunology · doi:10.1002/eji.1830191210 · Cited by 152
Self-citationKlingler, J., Weiß, S., Itri, V., Liu, X., Oguntuyo, K. Y., Stevens, C. S., Ikegame, S., Hung, C.-T., Enyindah-Asonye, G. M., Amanat, F., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa784 · Cited by 133
Callow, K. A. (1985) · Journal of Hygiene · doi:10.1017/s0022172400062410 · Cited by 119
Russell, M. W., Kilian, M., Mantis, N. J., & Corthésy, B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00021-5 · Cited by 119
Self-citationMestecky, J. F., Jackson, S., Moldoveanu, Z., Nesbit, L. R., Kulhavy, R., Prince, S. J., Sabbaj, S., Mulligan, M. J., & Goepfert, P. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2004.20.972 · Cited by 113
Self-citationIgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms.
Griffiss, J. M., & Goroff, D. K. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.6.2882 · Cited by 109
O’Sullivan, N. L., & Montgomery, P. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00099-9 · Cited by 93
Immunobiology of the Tonsils and Adenoids
Brandtzæg, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00103-8 · Cited by 79
Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells
Bidgood, S. R., Tam, J. C. H., McEwan, W. A., Mallery, D. L., & James, L. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410980111 · Cited by 78
Czerkinsky, C. C., Çuburu, N., Kweon, M., et al. (2011) · Human Vaccines · doi:10.4161/hv.7.1.13739 · Cited by 70
Boyaka, P. N., McGhee, J. R., Czerkinsky, C. C., & Mestecky, J. F. (2005) · Elsevier eBooks · doi:10.1016/b978-012491543-5/50051-6 · Cited by 68
Self-citationResistance of children to Covid-19. How?
Fischer, A. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0303-9 · Cited by 41
Woof, J. M., & Mestecky, J. F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00017-3 · Cited by 24
Self-citationImmunoglobulin Transport and Immunoglobulin Receptors
Baker, K., Blumberg, R. S., & Kaetzel, C. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00019-7 · Cited by 23
Russell, M. W. (2007) · Springer eBooks · doi:10.1007/978-0-387-72232-0_6 · Cited by 22
Self-citationLymphocyte Trafficking to Mucosal Tissues
Mikhak, Z., Agace, W. W., & Luster, A. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00040-9 · Cited by 13
Mestecky, J. F., & Hammarström, L. L. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-72232-0_13 · Cited by 11
Self-citation
Cited by
Mucosal vaccines — fortifying the frontiers
Lavelle, E. C., & Ward, R. W. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00583-2 · Cited by 752
Ndeupen, S., Qin, Z., Jacobsen, S., Bouteau, A., Estanbouli, H., & Igyártó, B. Z. (2021) · iScience · doi:10.1016/j.isci.2021.103479 · Cited by 678
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic: A Systematic Review
Oran, D. P., & Topol, E. J. (2021) · Annals of Internal Medicine · doi:10.7326/m20-6976 · Cited by 533
SARS-CoV-2 viral load and shedding kinetics
Puhach, O., Meyer, B., & Eckerle, I. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00822-w · Cited by 424
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Mistry, P., Barmania, F., Mellet, J., Peta, K., Strydom, A., Viljoen, I. M., James, W., Gordon, S., & Pepper, M. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.809244 · Cited by 299
Metadata
- Authors
- Russell, M. W., Moldoveanu, Z., Ogra, P. L., & Mestecky, J.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-11-30
- Volume
- 11
- Pages
- 611337-611337
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3109360305
- Cited by
- 389
- References
- 34
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.